# Special Drug Use-results Survey for Long-term Use (Fostamatinib)

> **NCT06757257** · — · RECRUITING · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 149 (estimated)

## Conditions studied

- Chronic Idiopathic Thrombocytopenic Purpura

## Interventions

- **DRUG:** fostamatinib

## Key facts

- **NCT ID:** NCT06757257
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-29
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 149 (ESTIMATED)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06757257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06757257, "Special Drug Use-results Survey for Long-term Use (Fostamatinib)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06757257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*